Survival is similar for patients with autoimmune disease treated with immune checkpoint inhibitors compared to patients with no autoimmune disease
Physician's Weekly,
1. There was no significant difference in efficacy of ICIs in cancer patients with or without AID. 2. Immune-related toxic…